Your browser doesn't support javascript.
loading
Targeting GPCRs and Their Signaling as a Therapeutic Option in Melanoma.
Raymond, Jérémy H; Aktary, Zackie; Larue, Lionel; Delmas, Véronique.
Affiliation
  • Raymond JH; Institut Curie, Université PSL, CNRS UMR3347, Inserm U1021, Normal and Pathological Development of Melanocytes, 91400 Orsay, France.
  • Aktary Z; Université Paris-Saclay, CNRS UMR3347, Inserm U1021, Signalisation Radiobiologie et Cancer, 91400 Orsay, France.
  • Larue L; Institut Curie, Université PSL, CNRS UMR3347, Inserm U1021, Normal and Pathological Development of Melanocytes, 91400 Orsay, France.
  • Delmas V; Université Paris-Saclay, CNRS UMR3347, Inserm U1021, Signalisation Radiobiologie et Cancer, 91400 Orsay, France.
Cancers (Basel) ; 14(3)2022 Jan 29.
Article in En | MEDLINE | ID: mdl-35158973
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Cancers (Basel) Year: 2022 Document type: Article Affiliation country: France Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Cancers (Basel) Year: 2022 Document type: Article Affiliation country: France Country of publication: Switzerland